Advertisement
Advertisement

SNOA

SNOA logo

Sonoma Pharmaceuticals Inc.

2.47
USD
-0.12
-4.63%
Dec 18, 11:46 UTC -5
Open

Sonoma Pharmaceuticals Inc. Profile

About

Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California.

Info & Links

CEO

Amy Trombly

Headquarters

5445 CONESTOGA COURT, SUITE 150
BOULDER, CO 80301, UNITED STATES

Auditor

Frazier & Deeter, LLC

Share holders

291

Employees

10

Sonoma Pharmaceuticals Inc. Statistics

Valuation Measures

Market Capitalization2

3.31M

Enterprise Value

-686.20K

Enterprise Value/EBITDA(ttm)

0.17

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.26

Price to Book(mrq)

0.48

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

38.70%

Operating Margin(ttm)

-25.46%

Profit Margin(ttm)

-27.34%

Return on Equity(ttm)

-59.58%

Return on Invested Capital(ttm)

-64.70%

Return on Assets(ttm)

-24.33%

Income Statement

Revenue(ttm)

13.55M

Revenue Per Share(ttm)

10.12

Gross Profit(ttm)

5.22M

EBITDA(ttm)3

-4.12M

Net Income Available to Common(ttm)

-3.69M

Diluted EPS(ttm)

-4.99

Share Statistics

Beta (5Y Monthly)

1.43

52-Week Change

-36.41%

S&P 500 52-Week Change

26.85%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.34M

Dividend Yield

0.00%

Float4

1.29M

% Held by Insiders

3.90%

% Held by Institutions

1.95%

Balance Sheet

Total Cash(mrq)

4.08M

Total Cash Per Share(mrq)

3.05

Total Debt(mrq)

82.00K

Total Debt/Equity(mrq)

1.53%

Current Ratio(mrq)

3.69%

Quick Ratio(mrq)

2.84%

Book Value Per Share(mrq)

4.00

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.54

Free Cash Flow(ytd)

-589.00K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement